RCEL Avita Medical, Inc. - Common Stock
$4,19
Fiyat · May 20, 2026
Temel veriler itibarıyla Şub 12, 2026
52 Haftlık Aralık
$3–$7
25% of range
Analist Derecelendirmesi
BUY
12 analysts
Fiyat Hedefi
$8
+88% upside
P/E (TTM)
-2.0
ROE
328.9%
Net Kâr Marjı
-67.8%
RCEL Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$4.19
Piyasa Değeri
$105M
P/E (TTM)
-2.0
EPS (TTM)
$-1.74
Gelir (TTM)
$72M
Temettü Verimi
—
ROE
328.9%
D/E Borç/Özsermaye
-2.6
52 Haftlık Aralık
$3 – $7
RCEL Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$72M
2018-06-30
→
2025-12-31
Hisse Başına Kâr
$-1.74
2018-06-30
→
2025-12-31
Serbest Nakit Akışı
$-32M
2021-06-30
→
2025-12-31
Marjlar
-67.8%
2021-06-30
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
RCEL
Akran Ortalaması
P/E (TTM)
-2.0
3.0
P/S (TTM) (F/S (TTM))
1.5
122.6
P/B (F/D)
-6.3
3.7
EV / EBITDA
-3.2
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-3.3
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
RCEL
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
82.1%
83.3%
Operating Margin (Faaliyet Kâr Marjı)
-59.4%
—
Net Profit Margin (Net Kâr Marjı)
-67.8%
-835.7%
ROA
-71.4%
-69.1%
ROE
328.9%
-81.8%
ROIC
-161.5%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
RCEL
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
-2.6
0.0
Current Ratio (Cari Oran)
0.6
6.9
Quick Ratio (Cari Oran)
0.4
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
RCEL
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
11.5%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
27.7%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
RCEL
Akran Ortalaması
RCEL Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
12 analist
- Güçlü Al 3 25,0%
- Al 6 50,0%
- Tut 3 25,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
4 analist · 2026-05-21
Medyan
$7.96
← Tüm hedeflerin altında
$4.19
Düşük
$5.42
Yüksek
$10.08
Medyan hedef
$7.96
+90,1%
Ortalama hedef
$7.86
+87,5%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.11%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.35 | $-0.29 | -0.06% |
| 31 Aralık 2025 | $-0.38 | $-0.34 | -0.04% |
| 30 Eylül 2025 | $-0.46 | $-0.29 | -0.17% |
| 30 Haziran 2025 | $-0.38 | $-0.25 | -0.13% |
| 31 Mart 2025 | $-0.53 | $-0.39 | -0.14% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| GALT | $271M | -8.7 | — | — | 25.0% | — |
| VTVT | — | — | — | — | -70.4% | — |
| SPRB | $120M | -1.7 | -51.3% | — | -139.9% | — |
| INDP | $6M | -0.1 | — | — | -2820.8% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| AGEN | $111M | — | 10.4% | -2.7% | 1.0% | — |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | — |
| CYPH | $97M | 16.6 | — | — | 6.1% | — |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | — |
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $64M | $50M | $34M | · | $29M | $14M | $5M | |
| Cost of Revenue | $13M | $9M | $8M | $6M | · | $6M | $3M | $1M | |
| Gross Profit | $59M | $55M | $42M | $28M | · | $23M | $11M | $4M | |
| R&D Expense | $21M | $20M | $21M | $14M | · | $15M | $9M | $8M | |
| SG&A Expense | $27M | $33M | $28M | $23M | · | $22M | $33M | $15M | |
| Operating Expenses | $101M | $112M | $86M | $59M | · | $52M | $58M | $36M | |
| Operating Income | $-43M | $-57M | $-43M | $-28M | · | $-27M | $-43M | $-26M | |
| Interest Expense | $5M | $5M | $1M | $16.0K | · | $22.0K | $33.0K | $27.0K | |
| Other Non-op | $-1M | $163.0K | $8M | $892.0K | · | · | · | · | |
| Pretax Income | $-49M | $-62M | $-35M | $-27M | · | $-27M | $-42M | $-25M | |
| Income Tax | $11.0K | $54.0K | $66.0K | $36.0K | · | $38.0K | $4.0K | $-121.0K | |
| Net Income | $-49M | $-62M | $-35M | $-27M | · | $-27M | $-42M | $-25M | |
| EPS (Basic) | $-1.74 | $-2.39 | $-1.40 | $1.07 | · | $1.17 | $2.07 | $1.56 | |
| EPS (Diluted) | $-1.74 | $-2.39 | $-1.40 | $1.07 | · | $1.17 | $2.07 | $1.56 | |
| Shares (Basic) | 27,860,784 | 25,883,056 | 25,331,264 | 25,000,180 | · | 22,674,313 | 20,290,966 | 16,064,588 | |
| Shares (Diluted) | 27,860,784 | 25,883,056 | 25,331,264 | 25,000,180 | · | 22,674,313 | 20,290,966 | 16,064,588 | |
| EBITDA | $-40M | $-55M | $-42M | $-27M | · | $-26M | · | · |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $14M | $22M | $18M | $56M | $111M | $74M | $20M | |
| Short-term Investments | $8M | $22M | $67M | $61M | $30M | · | · | · | |
| Receivables | $9M | $12M | $8M | $4M | $3M | $3M | $2M | $1M | |
| Inventory | $7M | $7M | $6M | $2M | $2M | $2M | $1M | $742.0K | |
| Prepaid Expense | $1M | $2M | $2M | $2M | $1M | $1M | $990.0K | $1M | |
| Other Current Assets | · | · | $18.0K | $127.0K | $15.0K | $480.0K | $75.0K | $125.0K | |
| Current Assets | $35M | $57M | $104M | $87M | $92M | $121M | $78M | $24M | |
| PP&E (Net) | $9M | $10M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Accum. Depreciation | $5M | $3M | $2M | $2M | $2M | $1M | $881.0K | $667.0K | |
| Intangibles | $6M | $6M | $487.0K | $465.0K | $443.0K | $472.0K | $364.0K | $225.0K | |
| Other Non-current Assets | $612.0K | $546.0K | $355.0K | $122.0K | $638.0K | $761.0K | $1.0K | $125.0K | |
| Total Assets | $56M | $80M | $112M | $98M | $116M | $126M | $82M | $26M | |
| Accounts Payable | $9M | $6M | $4M | $3M | $3M | $3M | $4M | $2M | |
| Current Liabilities | $63M | $20M | $13M | $11M | $9M | $7M | $8M | $4M | |
| Capital Leases | $2M | $3M | $2M | $306.0K | $918.0K | $878.0K | $2M | · | |
| Other Non-current Liabilities | · | · | · | · | $113.0K | $503.0K | $0 | $42.0K | |
| Total Liabilities | $73M | $75M | $62M | $13M | $11M | $10M | $10M | $5M | |
| Long-term Debt | $43M | $42M | · | · | · | · | · | · | |
| Total Debt | $43M | $42M | $40M | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $394M | $368M | $350M | $340M | $332M | $329M | $259M | $165M | |
| Retained Earnings | $-408M | $-360M | $-298M | $-263M | $-236M | $-221M | $-195M | $-153M | |
| AOCI | $-1M | $-2M | $-2M | $8M | $8M | $8M | $8M | $8M | |
| Stockholders' Equity | $-17M | $4M | $49M | $85M | $105M | $116M | $72M | $21M | |
| Liabilities + Equity | $56M | $80M | $112M | $98M | $116M | $126M | $82M | $26M | |
| Shares Outstanding | 30,571,662 | 26,354,042 | 25,682,078 | 25,208,436 | 24,925,743 | 24,895,864 | 21,467,912 | 18,712,996 |
Nakit Akışı 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $632.0K | $568.0K | · | $715.0K | $465.0K | $269.0K | |
| Stock-based Comp | $10M | $13M | $8M | $7M | · | $6M | $16M | $2M | |
| Amort. of Intangibles | $600.0K | $93.0K | $35.0K | $58.0K | · | $109.0K | $119.0K | $0 | |
| Other Non-cash | $6M | $-2M | $-12M | $9.0K | · | $-6M | · | · | |
| Operating Cash Flow | $-31M | $-49M | $-38M | $-19M | · | $-26M | $-23M | $-19M | |
| CapEx | $1M | $9M | $1M | $452.0K | · | $894.0K | $590.0K | $1M | |
| Investing Cash Flow | $12M | $37M | $2M | $-19M | · | $-1M | $-847.0K | $-1M | |
| Debt Issued | · | · | $39M | · | · | · | · | · | |
| Net Debt Issued | · | · | $39M | · | · | · | · | · | |
| Stock Issued | $15M | · | · | · | · | $69M | $82M | $32M | |
| Net Stock Activity | $15M | · | · | · | · | $69M | · | · | |
| Financing Cash Flow | $15M | $4M | $40M | $900.0K | · | $64M | $77M | $30M | |
| Net Change in Cash | $-4M | $-8M | $4M | $-38M | · | $37M | $53M | $9M | |
| Taxes Paid | $15.0K | $41.0K | $44.0K | $17.0K | · | · | · | · | |
| Free Cash Flow | $-32M | $-58M | $-39M | $-20M | · | $-27M | · | · | |
| Levered FCF | $-37M | $-63M | $-41M | $-20M | · | $-27M | · | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.1% | 85.9% | 84.5% | 82.5% | · | 79.7% | · | · | |
| Operating Margin | -59.4% | -88.1% | -85.1% | -79.9% | · | -90.8% | · | · | |
| Net Margin | -67.8% | -96.3% | -70.6% | -77.5% | · | -90.9% | · | · | |
| Pretax Margin | -67.8% | -96.2% | -70.4% | -77.4% | · | -90.8% | · | · | |
| EBITDA Margin | -56.1% | -86.3% | -83.8% | -78.3% | · | -88.3% | · | · | |
| ROA | -71.4% | -64.6% | -33.7% | -24.9% | · | -25.6% | · | · | |
| ROE | 328.9% | -739.5% | -63.2% | -30.9% | · | -22.7% | · | · | |
| ROIC | -161.5% | -121.2% | -48.1% | -32.5% | · | -23.0% | · | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | 2.8 | 7.9 | 8.2 | · | 16.4 | · | · | |
| Quick Ratio | 0.4 | 2.4 | 7.3 | 7.7 | · | 15.5 | · | · | |
| Debt / Equity | -2.6 | 9.4 | 0.8 | · | · | · | · | · | |
| LT Debt / Equity | 0.0 | 9.4 | 0.8 | · | · | · | · | · | |
| Interest Coverage | -8.5 | -10.6 | -37.3 | -1719.1 | · | -1206.4 | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 0.7 | 0.5 | 0.3 | · | 0.3 | · | · | |
| Inventory Turnover | 1.8 | 1.4 | 2.0 | 2.8 | · | 4.3 | · | · | |
| Receivables Turnover | 6.9 | 6.6 | 9.0 | 10.4 | · | 10.5 | · | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.5% | 28.1% | 45.7% | · | · | 105.0% | · | · | |
| Revenue CAGR 3Y | 27.7% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | · | -43.5% | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $72M | $64M | $50M | $34M | · | $29M | $14M | · | |
| Net Income TTM | $-49M | $-62M | $-35M | $-27M | · | $-27M | $-42M | · | |
| Market Cap | $105M | $337M | $352M | $166M | · | $511M | · | · | |
| Enterprise Value | $130M | $344M | $303M | · | · | · | · | · | |
| P/E | -2.0 | -5.4 | -9.8 | 6.2 | · | 17.5 | 14.8 | · | |
| P/S | 1.5 | 5.3 | 7.0 | 4.8 | · | 17.5 | · | · | |
| P/B | -6.3 | 75.0 | 7.2 | 2.0 | · | 4.4 | · | · | |
| P / Tangible Book | · | · | 7.3 | 2.0 | · | 4.4 | 9.1 | · | |
| P / Cash Flow | -3.4 | -6.9 | -9.3 | -8.7 | · | -19.7 | · | · | |
| P / FCF | -3.3 | -5.8 | -8.9 | -8.5 | · | -19.1 | · | · | |
| EV / EBITDA | -3.2 | -6.2 | -7.2 | · | · | · | · | · | |
| EV / FCF | -4.0 | -5.9 | -7.7 | · | · | · | · | · | |
| EV / Revenue | 1.8 | 5.3 | 6.0 | · | · | · | · | · | |
| Earnings Yield | -50.4% | -18.7% | -10.2% | 16.2% | · | 5.7% | 6.8% | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18M | $17M | $18M | $19M | $18M | $20M | $15M | $11M | $14M | $14M | $12M | $11M | $9M | $9M | $8M | $8M | |
| Cost of Revenue | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $2M | |
| Gross Profit | $14M | $14M | $15M | $16M | $16M | $16M | $13M | $10M | $12M | $12M | $10M | $9M | $8M | $8M | $7M | $6M | |
| R&D Expense | $6M | $4M | $5M | $6M | $5M | $5M | $5M | $5M | $7M | $4M | $5M | $5M | $3M | $4M | $3M | $4M | |
| SG&A Expense | $7M | $7M | $7M | $6M | $7M | $10M | $8M | $9M | $8M | $6M | $6M | $8M | $5M | $5M | $5M | $8M | |
| Operating Expenses | $25M | $23M | $26M | $28M | $26M | $30M | $29M | $27M | $25M | $21M | $21M | $19M | $15M | $14M | $14M | $16M | |
| Operating Income | $-10M | $-9M | $-11M | $-12M | $-10M | $-14M | $-16M | $-17M | $-12M | $-9M | $-11M | $-10M | $-6M | $-6M | $-6M | $-9M | |
| Interest Expense | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $10.0K | $7.0K | $4.0K | $-3.0K | $6.0K | $4.0K | · | |
| Other Non-op | $20.0K | $-3M | $2M | $-791.0K | $-314.0K | $-1M | $2M | $-66.0K | $6M | $615.0K | $801.0K | $725.0K | · | · | · | · | |
| Pretax Income | $-12M | $-13M | $-10M | $-14M | $-12M | $-16M | $-15M | $-19M | $-7M | $-9M | $-10M | $-9M | $-5M | $-6M | $-6M | $-9M | |
| Income Tax | $-16.0K | $15.0K | $4.0K | $8.0K | $19.0K | $-28.0K | $33.0K | $30.0K | $12.0K | $11.0K | $13.0K | $30.0K | $24.0K | $4.0K | $4.0K | $4.0K | |
| Net Income | $-12M | $-13M | $-10M | $-14M | $-12M | $-16M | $-15M | $-19M | $-7M | $-9M | $-10M | $-9M | $-5M | $-6M | $-6M | $-9M | |
| EPS (Basic) | $-0.37 | $-0.46 | $-0.38 | $-0.53 | $-0.44 | $-0.62 | $-0.60 | $-0.73 | $-0.28 | $-0.34 | $-0.41 | $-0.37 | $0.22 | $0.22 | $0.25 | $0.38 | |
| EPS (Diluted) | $-0.37 | $-0.46 | $-0.38 | $-0.53 | $-0.44 | $-0.62 | $-0.60 | $-0.73 | $-0.28 | $-0.34 | $-0.41 | $-0.37 | $0.22 | $0.22 | $0.25 | $0.38 | |
| Shares (Basic) | -53,153,774 | 28,393,445 | 26,367,548 | 26,253,565 | -51,498,934 | 25,983,929 | 25,760,278 | 25,637,783 | -50,512,301 | 25,401,754 | 25,239,723 | 25,202,088 | -49,916,057 | 25,006,995 | 24,971,243 | 24,937,999 | |
| Shares (Diluted) | -53,153,774 | 28,393,445 | 26,367,548 | 26,253,565 | -51,498,934 | 25,983,929 | 25,760,278 | 25,637,783 | -50,512,301 | 25,401,754 | 25,239,723 | 25,202,088 | -49,916,057 | 25,006,995 | 24,971,243 | 24,937,999 | |
| EBITDA | · | $-9M | $-11M | $-11M | · | $-14M | $-16M | $-17M | · | $-9M | $-11M | $-10M | · | $-6M | $-6M | $-9M |
Bilanço 26
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $15M | $12M | $15M | $14M | $19M | $17M | $17M | $22M | $51M | $37M | $28M | $18M | $24M | $35M | $24M | |
| Short-term Investments | $8M | $8M | $3M | $11M | $22M | $26M | $37M | $51M | $67M | $9M | $29M | $45M | $61M | $61M | $50M | $60M | |
| Receivables | $9M | $9M | $11M | $12M | $12M | $10M | $9M | $7M | $8M | $6M | $6M | $5M | $4M | $4M | $4M | $3M | |
| Inventory | $7M | $7M | $8M | $8M | $7M | $6M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $2M | $3M | $2M | $1M | $2M | $1M | $1M | $1M | |
| Other Current Assets | · | · | · | · | · | · | $8.0K | $135.0K | · | $26.0K | $525.0K | $29.0K | $127.0K | $17.0K | $29.0K | $27.0K | |
| Current Assets | $35M | $41M | $36M | $48M | $57M | $64M | $73M | $86M | $104M | $74M | $77M | $83M | $87M | $92M | $92M | $91M | |
| PP&E (Net) | $9M | $10M | $10M | $10M | $10M | $9M | $7M | $4M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Accum. Depreciation | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | $6M | $5M | $5M | $5M | $6M | $590.0K | $545.0K | $542.0K | $487.0K | $459.0K | $456.0K | $461.0K | $465.0K | $449.0K | $428.0K | $416.0K | |
| Other Non-current Assets | $612.0K | $1M | $839.0K | $287.0K | $546.0K | $546.0K | $473.0K | $401.0K | $355.0K | $236.0K | $285.0K | $230.0K | $122.0K | $548.0K | $1M | $1M | |
| Total Assets | $56M | $64M | $58M | $70M | $80M | $81M | $88M | $97M | $112M | $81M | $86M | $93M | $98M | $100M | $103M | $106M | |
| Accounts Payable | $9M | $8M | $7M | $9M | $6M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $2M | $2M | |
| Current Liabilities | $63M | $62M | $63M | $23M | $20M | $17M | $14M | $12M | $13M | $12M | $14M | $11M | $11M | $10M | $8M | $6M | |
| Capital Leases | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $306.0K | $405.0K | $532.0K | $726.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $715.0K | $571.0K | |
| Total Liabilities | $73M | $70M | $71M | $74M | $75M | $69M | $64M | $64M | $62M | $17M | $16M | $14M | $13M | $12M | $10M | $9M | |
| Long-term Debt | $43M | $42M | · | · | $42M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | $42M | $42M | $41M | · | $43M | $41M | $41M | · | · | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $394M | $393M | $374M | $371M | $368M | $364M | $359M | $353M | $350M | $347M | $344M | $342M | $340M | $338M | $337M | $335M | |
| Retained Earnings | $-408M | $-397M | $-384M | $-374M | $-360M | $-348M | $-332M | $-317M | $-298M | $-291M | $-282M | $-272M | $-263M | $-257M | $-252M | $-245M | |
| AOCI | $-1M | $-1M | $-2M | $-413.0K | $-2M | $-2M | $-2M | $-3M | $-2M | $8M | $8M | $8M | $8M | $7M | $8M | $8M | |
| Stockholders' Equity | $-17M | $-7M | $-13M | $-5M | $4M | $12M | $24M | $33M | $49M | $63M | $69M | $78M | $85M | $88M | $93M | $98M | |
| Liabilities + Equity | $56M | $64M | $58M | $70M | $80M | $81M | $88M | $97M | $112M | $81M | $86M | $93M | $98M | $100M | $103M | $106M | |
| Shares Outstanding | 30,571,662 | 30,493,111 | 26,613,678 | 26,434,658 | 26,354,042 | 26,217,629 | 25,949,906 | 25,789,051 | 25,682,078 | 25,550,694 | 25,447,615 | 25,327,761 | 25,208,436 | 25,030,902 | 25,003,088 | 24,955,581 |
Nakit Akışı 13
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $700.0K | $574.0K | $552.0K | $521.0K | $409.0K | $310.0K | $204.0K | $203.0K | $187.0K | $164.0K | $146.0K | $135.0K | $130.0K | $138.0K | $126.0K | $163.0K | |
| Stock-based Comp | $1M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $2M | $2M | $1M | $3M | $1M | $1M | $1M | $3M | |
| Amort. of Intangibles | $160.0K | $153.0K | $152.0K | $135.0K | $36.0K | $23.0K | $17.0K | $17.0K | $9.0K | $9.0K | $8.0K | $9.0K | $8.0K | $8.0K | $8.0K | $34.0K | |
| Other Non-cash | · | · | · | $335.0K | · | · | · | $-5M | · | · | · | $-3M | · | · | · | $-3M | |
| Operating Cash Flow | $-5M | $-5M | $-10M | $-10M | $-8M | $-7M | $-13M | $-21M | $-11M | $-9M | $-9M | $-9M | $-3M | $-3M | $-12M | $-9M | |
| CapEx | $-674.0K | $934.0K | $524.0K | $221.0K | $2M | $4M | $3M | $1M | $296.0K | $502.0K | $299.0K | $284.0K | $70.0K | $104.0K | $211.0K | $64.0K | |
| Investing Cash Flow | $11.0K | $-5M | $7M | $11M | $2M | $7M | $12M | $15M | $-57M | $22M | $18M | $19M | $-3M | $-8M | $42M | $-23M | |
| Stock Issued | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $248.0K | $14M | $559.0K | $363.0K | $1M | $1M | $849.0K | $631.0K | $39M | $600.0K | $171.0K | $171.0K | $899.0K | $0 | $-2.0K | $1.0K | |
| Net Change in Cash | $-5M | $3M | $-3M | $820.0K | $-5M | $1M | $501.0K | $-5M | $-29M | $13M | $9M | $10M | $-6M | $-11M | $29M | $-32M | |
| Taxes Paid | · | · | · | · | $20.0K | $2.0K | $19.0K | $17.0K | $0 | $0 | $44.0K | $9 | $0 | $0 | · | · | |
| Free Cash Flow | · | · | · | $-11M | · | · | · | $-22M | · | · | · | $-9M | · | · | · | $-9M | |
| Levered FCF | · | · | · | $-12M | · | · | · | $-23M | · | · | · | $-9M | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 81.3% | 81.2% | 84.7% | · | 83.7% | 86.1% | 86.4% | · | 84.5% | 81.2% | 84.2% | · | 83.2% | 83.4% | 76.4% | |
| Operating Margin | · | -53.6% | -60.5% | -63.9% | · | -70.6% | -102.8% | -155.0% | · | -68.2% | -95.0% | -93.9% | · | -63.2% | -76.3% | -125.8% | |
| Net Margin | · | -77.3% | -53.9% | -74.9% | · | -82.9% | -101.3% | -168.0% | · | -63.8% | -88.3% | -87.4% | · | -61.5% | -75.1% | -125.5% | |
| Pretax Margin | · | -77.2% | -53.8% | -74.8% | · | -83.0% | -101.1% | -167.8% | · | -63.8% | -88.2% | -87.1% | · | -61.4% | -75.1% | -125.5% | |
| EBITDA Margin | · | -53.6% | -60.5% | -61.1% | · | -70.6% | -102.8% | -153.1% | · | -68.2% | -95.0% | -92.7% | · | -63.2% | -76.3% | -123.7% | |
| ROA | · | -18.2% | -13.6% | -16.6% | · | -20.0% | -17.7% | -19.6% | · | -9.6% | -11.0% | -9.3% | · | -4.9% | -7.3% | -8.3% | |
| ROE | · | -474.3% | -180.0% | -99.0% | · | -43.1% | -33.3% | -33.9% | · | -11.5% | -12.9% | -10.5% | · | -5.4% | -8.2% | -9.0% | |
| ROIC | · | -25.6% | -38.0% | -32.1% | · | -25.2% | -24.1% | -23.3% | · | -14.8% | -16.3% | -12.8% | · | -6.5% | -6.9% | -9.7% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.7 | 0.6 | 2.1 | · | 3.7 | 5.3 | 7.2 | · | 6.2 | 5.6 | 7.2 | · | 9.6 | 11.6 | 14.0 | |
| Quick Ratio | · | 0.5 | 0.4 | 1.6 | · | 3.2 | 4.6 | 6.3 | · | 5.6 | 5.2 | 6.8 | · | 9.2 | 11.2 | 13.4 | |
| Debt / Equity | · | -6.4 | -3.3 | -9.1 | · | 3.5 | 1.7 | 1.3 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | 0.0 | -3.3 | -9.1 | · | 3.5 | 1.7 | 1.3 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | -7.2 | -8.9 | -9.6 | · | -10.2 | -11.6 | -12.7 | · | -930.6 | -1595.0 | -2477.8 | · | -958.0 | -1590.5 | · |
Verimlilik 3
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Inventory Turnover | · | 0.5 | 0.5 | 0.4 | · | 0.6 | 0.4 | 0.3 | · | 0.7 | 0.9 | 0.7 | · | 0.8 | 0.6 | 1.0 | |
| Receivables Turnover | · | 1.8 | 1.8 | 1.9 | · | 2.4 | 2.1 | 1.9 | · | 2.9 | 2.4 | 2.6 | · | 3.1 | 2.9 | 2.3 |
Değerleme (TTM) 14
| Metrik | Eğilim | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $74M | $72M | $64M | · | $59M | $52M | $47M | · | $45M | $40M | $36M | · | $32M | $30M | $32M | |
| Net Income TTM | · | $-53M | $-55M | $-64M | · | $-59M | $-53M | $-47M | · | $-34M | $-31M | $-31M | · | $-27M | $-28M | $-26M | |
| Market Cap | · | $156M | $141M | $215M | · | $281M | $206M | $413M | · | $373M | $433M | $354M | · | $132M | $119M | $212M | |
| Enterprise Value | · | $175M | $167M | $231M | · | $279M | $192M | $387M | · | · | · | · | · | · | · | · | |
| P/E | · | -2.6 | -2.5 | -3.3 | · | -4.7 | -3.8 | -8.7 | · | -16.2 | -54.9 | 29.1 | · | 4.8 | 4.3 | 8.1 | |
| P/S | · | 2.1 | 2.0 | 3.3 | · | 4.7 | 4.0 | 8.8 | · | 8.3 | 10.9 | 10.0 | · | 4.1 | 4.0 | 6.6 | |
| P/B | · | -23.4 | -10.9 | -47.1 | · | 23.0 | 8.6 | 12.7 | · | 5.9 | 6.3 | 4.6 | · | 1.5 | 1.3 | 2.2 | |
| P / Tangible Book | · | · | · | · | · | 24.2 | 8.8 | 12.9 | · | 6.0 | 6.3 | 4.6 | · | 1.5 | 1.3 | 2.2 | |
| P / Cash Flow | · | · | · | -20.9 | · | · | · | -19.8 | · | · | · | -39.0 | · | · | · | -22.6 | |
| P / FCF | · | · | · | -20.4 | · | · | · | -18.8 | · | · | · | -37.8 | · | · | · | -22.4 | |
| EV / EBITDA | · | -19.1 | -15.0 | -20.4 | · | -20.2 | -12.3 | -22.7 | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | · | -21.9 | · | · | · | -17.6 | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 2.4 | 2.3 | 3.6 | · | 4.7 | 3.7 | 8.2 | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | -38.9% | -40.3% | -30.5% | · | -21.4% | -26.3% | -11.5% | · | -6.2% | -1.8% | 3.4% | · | 20.7% | 23.4% | 12.4% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $72M | $64M | $50M | $34M | — |
| Brüt Kâr Marjı % | 82.1% | 85.9% | 84.5% | 82.5% | — |
| Faaliyet Kâr Marjı % | -59.4% | -88.1% | -85.1% | -79.9% | — |
| Net Gelir | $-49M | $-62M | $-35M | $-27M | — |
| Seyreltilmiş Hisse Başı Kâr | $-1.74 | $-2.39 | $-1.40 | $1.07 | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -2.6 | 9.4 | 0.8 | — | — |
| Cari Oran | 0.6 | 2.8 | 7.9 | 8.2 | — |
| Cari Oran | 0.4 | 2.4 | 7.3 | 7.7 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-32M | $-58M | $-39M | $-20M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.